高级视觉化市场按产品、解决方案类型、显像模式、应用、最终用户和地区划分 - 预测至 2029 年
市场调查报告书
商品编码
1655431

高级视觉化市场按产品、解决方案类型、显像模式、应用、最终用户和地区划分 - 预测至 2029 年

Advanced Visualization Market by Type (Enterprise, Standalone), Modality (MRI, CT, PET, Ultrasound, Radiotherapy, Nuclear Medicine), Application (Radiology, Oncology, Neuro), End User (Hospital, ASC, Diagnostic Center) & Region - Global Forecast to 2029

出版日期: | 出版商: MarketsandMarkets | 英文 331 Pages | 订单完成后即时交付

价格

全球高阶视觉化市场规模预计将从 2024 年的 37.8 亿美元成长到 2029 年的 65.5 亿美元,预测期内的复合年增长率为 11.7%。

由于公共和私人组织的投资和资金不断增加,以及心臟病学、放射学、神经病学、肿瘤学等行业各个应用领域对技术先进的可视化解决方案的需求激增,预计市场将会成长。此外,由于整个医疗保健产业对改善影像处理技术的需求,市场也不断成长。然而,新兴国家IT基础设施不足和不愿采用先进的视觉化解决方案预计将对市场成长构成挑战。

研究范围
调查年份 2022-2029
基准年 2023
预测期 2024-2029
考虑单位 金额(美元)
部分 按产品、按解决方案类型、按显像模式、按应用、按最终用户、按地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

高级视觉化软体部分子区隔为内部部署和云端基础的。 2023 年,预计云端基础领域将在预测期内实现最高成长。云端运算部分的成长归功于此模式提供的许多好处,例如来自各个资料孤岛的无缝整合、来自远端位置的无限用户存取、低维护成本、高安全性、隐私性、易于存取、无需前期投资、极大的灵活性和优化的资源利用率。此外,对远端医疗服务和远端医疗的需求不断增长,加速了云端技术的采用,这使得人们可以轻鬆存取影像处理工具并促进医疗保健专业人员之间的资料共用,进一步促进了该行业的发展。

医院和门诊手术中心、诊断和影像中心、学术和研究中心以及其他最终用户构成了高级视觉化市场的最终用户群。 2023 年,医院和门诊手术中心将占据最终用户的高级视觉化市场的大部分份额。此外,预计该部分将在预测期内实现最高成长。该领域的突出地位和高增长是由于影像资料的日益复杂、对准确诊断和手术计划的需求、微创手术的增加以及与现有系统互通性的需求所推动的。此外,个人化医疗和精准治疗的推动以及人工智慧和机器学习的融合,进一步提高了服务提供者行业内高级视觉性的价值。

高级视觉化市场细分为北美、欧洲、亚太、拉丁美洲和中东及非洲。预计亚太地区将在预测期内实现最高成长。该地区的高成长可以归因于该地区患者人数的庞大和不断增长、对创新治疗的需求不断增加、医疗保健巨量资料的出现、对 HCIT 基础设施的支出不断增加以及各市场参与者的重点转向该地区的新兴国家。政府采取措施推动医疗保健产业采用数位化和技术型解决方案,并高度重视在工作流程中整合先进技术,这也促进了医疗保健产业的成长。

本报告研究了全球高级视觉化市场,并根据产品、解决方案类型、显像模式、应用、最终用户、区域趋势和公司概况提供了详细的细分。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章 市场概况

  • 介绍
  • 市场动态
  • 影响客户业务的趋势/干扰
  • 定价分析
  • 价值链分析
  • 生态系分析
  • 投资金筹措场景
  • 技术分析
  • 产业趋势
  • 专利分析
  • 2025-2026 年重要会议与活动
  • 案例研究分析
  • 监管状态
  • 波特五力分析
  • 主要相关人员和采购标准
  • 最终用户分析
  • 先进的可视化经营模式
  • 人工智慧/生成式人工智慧对高阶视觉化市场的影响

第 6 章 高阶视觉化市场(依产品分类)

  • 介绍
  • 服务
  • 软体
  • 硬体

第 7 章 进阶视觉化市场(按解决方案类型)

  • 介绍
  • 企业范围的基于精简型用户端的解决方案
  • 基于独立工作站的解决方案

第 8 章 高阶视觉化市场(依显像模式)

  • 介绍
  • 磁振造影
  • 电脑断层扫描
  • 正子断层扫描
  • 超音波
  • 放射治疗
  • 核子医学
  • 其他的

第 9 章 高阶视觉化市场(按应用)

  • 介绍
  • 放射/介入放射学
  • 心臟病
  • 整形外科
  • 肿瘤学
  • 血管医学
  • 神经科
  • 其他的

第 10 章 进阶视觉化市场(依最终使用者划分)

  • 介绍
  • 医院及门诊手术中心
  • 诊断与影像中心
  • 学术研究中心
  • 其他的

第 11 章 高阶视觉化市场(按地区)

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 日本
    • 中国
    • 印度
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 中东和非洲宏观经济展望
    • 海湾合作委员会国家
    • 其他的

第十二章 竞争格局

  • 概述
  • 主要参与企业的策略/优势,2021 年 1 月至 2024 年 12 月
  • 2019 至 2023 年收益分析
  • 2023 年市场占有率分析
  • 公司估值与财务指标
  • 品牌/产品比较
  • 公司估值矩阵:主要参与企业,2023 年
  • 公司估值矩阵:Start-Ups/中小企业,2023 年
  • 竞争场景

第十三章 公司简介

  • 主要参与企业
    • AGFA-GEVAERT GROUP
    • CANON MEDICAL SYSTEMS CORPORATION
    • FUJIFILM HOLDINGS CORPORATION
    • GE HEALTHCARE
    • SIEMENS HEALTHINEERS AG
    • KONINKLIJKE PHILIPS NV
    • STRYKER
    • CHANGE HEALTHCARE(UNITEDHEALTH GROUP)
    • TERARECON
    • ZIOSOFT
    • PRO MEDICUS, LTD.
    • CARESTREAM HEALTH
    • FOVIA, INC.
    • 4DMEDICAL
    • SYNOPSYS, INC.
    • NOVARAD
    • ANALYZEDIRECT, INC.
    • SYNTERMED INC.
    • PIE MEDICAL IMAGING BV
    • INFINITT HEALTHCARE CO., LTD.
  • 其他公司
    • BIOTRONICS 3D
    • MINNOVAA INNOVATIONS OU
    • POSTDICOM
    • CITIUSTECH INC.
    • CEEVRA, INC.

第十四章 附录

Product Code: HIT 3515

The global Advanced visualization market is projected to reach USD 6.55 billion by 2029 from USD 3.78 billion in 2024, at a CAGR of 11.7% during the forecast period. The market is expected to grow as a result of the increasing investments & fundings by public-private organizations, surging demand for technologically advanced visualization solutions for various applications across the industry, such as, cardiology, radiology, neurology, oncology, among others. Moreover, the market has experienced growth due to the need for improved imaging techniques across healthcare industry. However, insufficient IT infrastructure, and reluctance towards adoption of advanced visualization solutions in emerging economies are some of the factors that are expected to pose a challenge to the market growth.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsOffering, Solution Type, Imaging Modality, Application, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

"Cloud-based subsegment, under the advanced visualization software segment is expected to register highest growth during the forecast period."

The advanced visualization software segment is sub-segmented into on-premise and cloud-based. In 2023, the cloud-based segment is expected to register the highest growth during the forecast period. The growth of the cloud segment is attributed to the ample number of advantages offered by this model, such as the seamless integration of data from various silos, unlimited user access from remote locations, low maintenance costs, high security, privacy, easy accessibility, no upfront capital investment for hardware, and extreme capacity flexibility and optimized resource utilization. Moreover, the increasing demand for remote healthcare services and telemedicine solutions has accelerated the adoption of cloud technologies that facilitate easy access to imaging tools and data sharing among healthcare professionals, further contributing to the segment's growth.

"Hospitals & Ambulatory Surgical Centers is projected to dominate the market in the advanced visualization market, by end user during the forecast period."

The hospitals & ambulatory surgical centers, diagnostic & imaging centers, academic & research centers, and other end users make up the end user segments of the advanced visualization market. In 2023, the hospitals & ambulatory surgical centers accounted for a significant share of the advanced visualization market, by end user. The segment is also expected to register paramount growth during the forecast period. The prominent position & high growth of this segment is due to the increasing complexity of imaging data, demand for precise diagnostics & surgical planning, rise in minimally-invasive procedures, and the need for interoperability with existing systems. Moreover, the push for personalized medicine and precision therapeutics, the integration of AI and machine learning further strengthens the value of advanced visualization in the provider industry.

"Asia Pacific is expected to register highest market growth during the forecast period."

The advanced visualization market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to register highest growth during the forecast period. The high growth of this region is attributed to the the presence of a large and growing patient population in the region, the increasing need for innovative therapies, the emergence of big data in healthcare, increasing spending on HCIT infrastructure, and the shifting focus of various market players on emerging countries in the region. Government initiatives to promote the adoption of digital & technologically enabled solutions across healthcare industry, and significant focus on integrating sophisticated technologies across the workflows also contributes to the growth.

The break-down of primary participants is as mentioned below:

  • By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
  • By Designation - Directors: 30%, Manager: 34%, and Others: 36%
  • By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%

List of Companies Profiled in the Report

    • Agfa-Gevaert Group (Belgium)
    • Canon Medical Systems Corporation (Japan)
    • Fujifilm Holdings Corporation (Japan)
    • GE Healthcare (US)
    • Koninklijke Philips N.V. (Netherlands)
    • Siemens Healthineers AG (Germany)
    • Stryker (US)
    • Change Healthcare (US)
    • TeraRecon (US)
    • Ziosoft (Japan)
    • Pro Medicus, Ltd (Australia)
    • Carestream Health (US)
    • Fovia, Inc. (US)
    • 4DMedical (Australia)
    • Synopsys, Inc. (US)
    • Novarad (US)
    • AnalyzeDirect, Inc. (US)
    • Syntermed Inc. (Netherlands)
    • Pie Medical Imaging B.V. (Netherlands)
    • Infinitt Healthcare Co., Ltd. (US)
    • Biotronics 3D (UK)
    • Minnovaa Innovations Ou (Estonia)
    • Postdicom (Netherlands)
    • CitiusTech Inc (US)
    • Ceevra, Inc. (US)

Research Coverage:

The report analyzes the advanced visualization market and aims to estimate the market size and future growth potential of various market segments, based on offering, solution type, imaging modality, applicarion, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total advanced visualization market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of key drivers (booming geriatric population, growing advancements in picture archiving and communication systems and advanced visualization, rising investments by government and private organizations, increasing need for early disease diagnosis), restraints (limited availability of reimbursements, high deployment cost of advanced visualization tools), opportunities (expanding modernization efforts in emerging economies, growing adoption of artificial intelligence and machine learning, increasing establishment of hospitals and diagnostic imaging centers), challenges (shortage of skilled personnel, declining budget allocation for health services) are factors contributing the growth of the advanced visualization market.
  • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the advanced visualization market.
  • Market Development: Comprehensive information on the lucrative emerging markets, type of solution, component, deployment model, industry, and region.
  • Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the advanced visualization market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global advanced visualization market such as Agfa-Gevaert Group (Belgium), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ADVANCED VISUALIZATION MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY OFFERING AND COUNTRY
  • 4.3 ADVANCED VISUALIZATION MARKET, BY COUNTRY
  • 4.4 ADVANCED VISUALIZATION MARKET: REGIONAL MIX
  • 4.5 ADVANCED VISUALIZATION MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Booming geriatric population
      • 5.2.1.2 Growing advancements in picture archiving and communication systems and advanced visualization
      • 5.2.1.3 Rising investments by government and private organizations
      • 5.2.1.4 Increasing need for early disease diagnosis
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Limited availability of reimbursements
      • 5.2.2.2 High deployment cost of advanced visualization tools
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Expanding modernization efforts in emerging economies
      • 5.2.3.2 Growing adoption of artificial intelligence and machine learning
      • 5.2.3.3 Increasing establishment of hospitals and diagnostic imaging centers
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled personnel
      • 5.2.4.2 Declining budget allocation for health services
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 PRICING ANALYSIS
    • 5.4.1 INDICATIVE SELLING PRICE, BY OFFERING
    • 5.4.2 INDICATIVE SELLING PRICE, BY REGION
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
  • 5.7 INVESTMENT AND FUNDING SCENARIO
  • 5.8 TECHNOLOGY ANALYSIS
    • 5.8.1 KEY TECHNOLOGIES
      • 5.8.1.1 Machine learning and artificial intelligence
      • 5.8.1.2 Augmented reality and virtual reality
      • 5.8.1.3 Cloud computing
    • 5.8.2 COMPLEMENTARY TECHNOLOGIES
      • 5.8.2.1 Bioinformatics tools
      • 5.8.2.2 Big data analytics
      • 5.8.2.3 Internet of things
    • 5.8.3 ADJACENT TECHNOLOGIES
      • 5.8.3.1 Blockchain
      • 5.8.3.2 Quantum computing
  • 5.9 INDUSTRY TRENDS
    • 5.9.1 INTEGRATION OF ADVANCED VISUALIZATION SOLUTIONS WITH DATA-SHARING MODALITIES
    • 5.9.2 INTEGRATION OF ADVANCED VISUALIZATION SOLUTIONS WITH PICTURE ARCHIVING AND COMMUNICATION SYSTEMS
  • 5.10 PATENT ANALYSIS
  • 5.11 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.12 CASE STUDY ANALYSIS
    • 5.12.1 ENHANCED LEARNING EXPERIENCE USING ADVANCED VISUALIZATION TECHNIQUES
    • 5.12.2 IMPROVED DETERMINATION AND SIMULATION OF LYMPH NODE BY 3D RECONSTRUCTION
    • 5.12.3 ENHANCED DECISION-MAKING AND TRACKING OF TUMOR PROGRESSION WITH VISUALIZATION TOOLS
  • 5.13 REGULATORY LANDSCAPE
    • 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.13.2 REGULATORY ANALYSIS
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • 5.14.1 THREAT OF NEW ENTRANTS
    • 5.14.2 THREAT OF SUBSTITUTES
    • 5.14.3 BARGAINING POWER OF SUPPLIERS
    • 5.14.4 BARGAINING POWER OF BUYERS
    • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.15.2 BUYING CRITERIA
  • 5.16 END-USER ANALYSIS
    • 5.16.1 UNMET NEEDS
    • 5.16.2 END-USER EXPECTATIONS
  • 5.17 ADVANCED VISUALIZATION BUSINESS MODELS
    • 5.17.1 SUBSCRIPTION-BASED MODEL
    • 5.17.2 SAAS MODEL
    • 5.17.3 ENTERPRISE LICENSING
    • 5.17.4 FREEMIUM MODEL
    • 5.17.5 CONSULTING SERVICES MODEL
    • 5.17.6 PARTNERSHIP/REVENUE-SHARING MODEL
    • 5.17.7 HYBRID MODEL
    • 5.17.8 SERVICE MODEL
  • 5.18 IMPACT OF AI/GENERATIVE AI ON ADVANCED VISUALIZATION MARKET
    • 5.18.1 INTRODUCTION
    • 5.18.2 MARKET POTENTIAL OF ADVANCED VISUALIZATION
    • 5.18.3 AI USE CASES IN ADVANCED VISUALIZATION
      • 5.18.3.1 Key use cases of AI
      • 5.18.3.2 Potential use cases of gen AI
    • 5.18.4 CASE STUDY
    • 5.18.5 IMPACT OF GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
      • 5.18.5.1 Diagnostic procedures
      • 5.18.5.2 Personalized treatment
      • 5.18.5.3 Predictive patient care
      • 5.18.5.4 Operational efficiency
      • 5.18.5.5 Healthcare imaging
    • 5.18.6 USER READINESS AND IMPACT ASSESSMENT
      • 5.18.6.1 User readiness
        • 5.18.6.1.1 Hospitals & ambulatory surgical centers
        • 5.18.6.1.2 Diagnostic & imaging centers
        • 5.18.6.1.3 Academic & research centers
      • 5.18.6.2 Impact assessment
        • 5.18.6.2.1 User A: Hospitals & ambulatory surgical centers
          • 5.18.6.2.1.1 Implementation
          • 5.18.6.2.1.2 Impact
        • 5.18.6.2.2 User B: Diagnostic & imaging centers
          • 5.18.6.2.2.1 Implementation
          • 5.18.6.2.2.2 Impact
        • 5.18.6.2.3 User C: Academic & research centers
          • 5.18.6.2.3.1 Implementation
          • 5.18.6.2.3.2 Impact

6 ADVANCED VISUALIZATION MARKET, BY OFFERING

  • 6.1 INTRODUCTION
  • 6.2 SERVICES
    • 6.2.1 IMPLEMENTATION SERVICES
      • 6.2.1.1 Rising installation of advanced visualization solutions in hospitals & diagnostic centers to sustain growth
    • 6.2.2 CONSULTING/OPTIMIZATION SERVICES
      • 6.2.2.1 Increasing adoption of enhanced workflow practices to support growth
    • 6.2.3 TRAINING & EDUCATION SERVICES
      • 6.2.3.1 Growing adoption of technologically advanced 3D imaging software to drive market
    • 6.2.4 POST-SALES & MAINTENANCE SERVICES
      • 6.2.4.1 Increasing availability of advanced visualization solutions to propel market
  • 6.3 SOFTWARE
    • 6.3.1 ON-PREMISE SOFTWARE
      • 6.3.1.1 Rising focus on enhanced patient care and operational efficiency to augment growth
    • 6.3.2 CLOUD-BASED SOFTWARE
      • 6.3.2.1 Increasing demand for remote healthcare services and telemedicine to accelerate growth
  • 6.4 HARDWARE
    • 6.4.1 GROWING DEMAND FOR HIGH-QUALITY IMAGING IN SPECIALIZED FIELDS TO BOOST MARKET

7 ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE

  • 7.1 INTRODUCTION
  • 7.2 ENTERPRISE-WIDE THIN CLIENT-BASED SOLUTIONS
    • 7.2.1 NEED TO IMPROVE DIAGNOSTIC CAPABILITIES ACROSS HEALTHCARE FACILITIES TO DRIVE MARKET
  • 7.3 STANDALONE WORKSTATION-BASED SOLUTIONS
    • 7.3.1 INCREASING COMPLEXITY OF MEDICAL IMAGING DATA TO FACILITATE GROWTH

8 ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY

  • 8.1 INTRODUCTION
  • 8.2 MAGNETIC RESONANCE IMAGING
    • 8.2.1 INCREASING INSTALLATIONS OF MAGNETIC RESONANCE IMAGING MACHINES TO SUSTAIN GROWTH
  • 8.3 COMPUTED TOMOGRAPHY
    • 8.3.1 RISING NEED FOR PRECISE ASSESSMENT OF COMPLEX ANATOMICAL STRUCTURES TO DRIVE MARKET
  • 8.4 POSITRON EMISSION TOMOGRAPHY
    • 8.4.1 GROWING ADOPTION OF ADVANCED VISUALIZATION IN ONCOLOGY, NEUROLOGY, AND CARDIOLOGY TO BOOST MARKET
  • 8.5 ULTRASOUND
    • 8.5.1 GROWING PREFERENCE OF HEALTHCARE PROFESSIONALS FOR ADVANCED ULTRASOUND TO PROPEL MARKET
  • 8.6 RADIOTHERAPY
    • 8.6.1 RISING DEMAND FOR PERSONALIZED AND PRECISE CANCER TREATMENT TO PROMOTE GROWTH
  • 8.7 NUCLEAR MEDICINE
    • 8.7.1 NEED TO ASSESS HEALTH AND FUNCTIONING OF CRITICAL ORGANS TO SUPPORT GROWTH
  • 8.8 OTHER IMAGING MODALITIES

9 ADVANCED VISUALIZATION MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 RADIOLOGICAL/INTERVENTIONAL RADIOLOGICAL APPLICATIONS
    • 9.2.1 ONGOING TREND OF PROCESS AUTOMATION AND WORKFLOW DIGITIZATION TO AUGMENT GROWTH
  • 9.3 CARDIOLOGICAL APPLICATIONS
    • 9.3.1 GROWING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
  • 9.4 ORTHOPEDIC APPLICATIONS
    • 9.4.1 INCREASING ADVANCEMENTS IN HOLOGRAPHIC TECHNOLOGY AND VIRTUAL REALITY TO EXPEDITE GROWTH
  • 9.5 ONCOLOGICAL APPLICATIONS
    • 9.5.1 RISING INCIDENCE OF CANCER TO CONTRIBUTE TO SEGMENT GROWTH
  • 9.6 VASCULAR APPLICATIONS
    • 9.6.1 NEED FOR PRECISE IMAGING TO SUSTAIN GROWTH
  • 9.7 NEUROLOGICAL APPLICATIONS
    • 9.7.1 GROWING ADVANCEMENTS IN NEUROIMAGING TECHNIQUES TO FUEL MARKET
  • 9.8 OTHER APPLICATIONS

10 ADVANCED VISUALIZATION MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS & AMBULATORY SURGICAL CENTERS
    • 10.2.1 HIGH ADOPTION RATE OF DIAGNOSTIC PROCEDURES FOR EARLY DISEASE DETECTION TO CONTRIBUTE TO GROWTH
  • 10.3 DIAGNOSTIC & IMAGING CENTERS
    • 10.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO FAVOR GROWTH
  • 10.4 ACADEMIC & RESEARCH CENTERS
    • 10.4.1 GROWING NUMBER OF FUNDS AND GRANTS FOR RESEARCH ACTIVITIES TO DRIVE MARKET
  • 10.5 OTHER END USERS

11 ADVANCED VISUALIZATION MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 Continuous technological advancements in diagnostic imaging modalities to promote growth
    • 11.2.3 CANADA
      • 11.2.3.1 Increasing prevalence of heart ailments to expedite growth
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Rapid growth of diagnostic imaging research activities and outsourcing of testing to boost market
    • 11.3.3 UK
      • 11.3.3.1 Rising acceptance of advanced diagnostic imaging techniques to aid growth
    • 11.3.4 FRANCE
      • 11.3.4.1 Easy accessibility to diagnostic assay procedures and availability of low-cost surgical facilities to spur growth
    • 11.3.5 SPAIN
      • 11.3.5.1 Increasing access to advanced cancer screening programs to stimulate growth
    • 11.3.6 ITALY
      • 11.3.6.1 Growing adoption of digitized diagnostic techniques to fuel market
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 JAPAN
      • 11.4.2.1 Favorable reimbursement system and growing access to healthcare systems to propel market
    • 11.4.3 CHINA
      • 11.4.3.1 Changing lifestyle and growing purchasing power to accelerate growth
    • 11.4.4 INDIA
      • 11.4.4.1 Rising trend of medical tourism to augment growth
    • 11.4.5 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Free and universal public health system to contribute to market growth
    • 11.5.3 MEXICO
      • 11.5.3.1 Growing adoption of advanced devices to fuel market
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 11.6.2 GCC COUNTRIES
      • 11.6.2.1 Growing focus on improving healthcare services and infrastructure to drive market
    • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2021-DECEMBER 2024
  • 12.3 REVENUE ANALYSIS, 2019-2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.6 BRAND/PRODUCT COMPARISON
  • 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.7.1 STARS
    • 12.7.2 EMERGING LEADERS
    • 12.7.3 PERVASIVE PLAYERS
    • 12.7.4 PARTICIPANTS
    • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.7.5.1 Company footprint
      • 12.7.5.2 Application footprint
      • 12.7.5.3 Solution type footprint
      • 12.7.5.4 Imaging modality footprint
      • 12.7.5.5 Component footprint
      • 12.7.5.6 End-user footprint
      • 12.7.5.7 Region footprint
  • 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.8.1 PROGRESSIVE COMPANIES
    • 12.8.2 RESPONSIVE COMPANIES
    • 12.8.3 DYNAMIC COMPANIES
    • 12.8.4 STARTING BLOCKS
    • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 12.8.5.1 Detailed list of key startups/SMEs
      • 12.8.5.2 Competitive benchmarking of key startups/SMEs
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES AND UPGRADES
    • 12.9.2 DEALS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 AGFA-GEVAERT GROUP
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products/Solutions/Services offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Deals
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Right to win
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses and competitive threats
    • 13.1.2 CANON MEDICAL SYSTEMS CORPORATION
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products/Solutions/Services offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Deals
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Right to win
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses and competitive threats
    • 13.1.3 FUJIFILM HOLDINGS CORPORATION
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products/Solutions/Services offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Product launches and upgrades
        • 13.1.3.3.2 Deals
    • 13.1.4 GE HEALTHCARE
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products/Solutions/Services offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Product launches and upgrades
        • 13.1.4.3.2 Deals
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Right to win
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses and competitive threats
    • 13.1.5 SIEMENS HEALTHINEERS AG
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products/Solutions/Services offered
      • 13.1.5.3 MnM view
        • 13.1.5.3.1 Right to win
        • 13.1.5.3.2 Strategic choices
        • 13.1.5.3.3 Weaknesses and competitive threats
    • 13.1.6 KONINKLIJKE PHILIPS N.V.
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products/Solutions/Services offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Product launches and upgrades
        • 13.1.6.3.2 Deals
      • 13.1.6.4 MnM view
        • 13.1.6.4.1 Right to win
        • 13.1.6.4.2 Strategic choices
        • 13.1.6.4.3 Weaknesses and competitive threats
    • 13.1.7 STRYKER
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products/Solutions/Services offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Product launches and upgrades
        • 13.1.7.3.2 Deals
    • 13.1.8 CHANGE HEALTHCARE (UNITEDHEALTH GROUP)
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products/Solutions/Services offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Deals
    • 13.1.9 TERARECON
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products/Solutions/Services offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Product launches and upgrades
        • 13.1.9.3.2 Deals
    • 13.1.10 ZIOSOFT
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products/Solutions/Services offered
      • 13.1.10.3 Recent developments
        • 13.1.10.3.1 Product launches and upgrades
    • 13.1.11 PRO MEDICUS, LTD.
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products/Solutions/Services offered
      • 13.1.11.3 Recent developments
        • 13.1.11.3.1 Other Developments
    • 13.1.12 CARESTREAM HEALTH
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products/Solutions/Services offered
      • 13.1.12.3 Recent developments
        • 13.1.12.3.1 Product launches and upgrades
    • 13.1.13 FOVIA, INC.
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products/Solutions/Services offered
      • 13.1.13.3 Recent developments
        • 13.1.13.3.1 Deals
    • 13.1.14 4DMEDICAL
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products/Solutions/Services offered
      • 13.1.14.3 Recent developments
        • 13.1.14.3.1 Deals
    • 13.1.15 SYNOPSYS, INC.
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products/Solutions/Services offered
      • 13.1.15.3 Recent developments
        • 13.1.15.3.1 Deals
    • 13.1.16 NOVARAD
      • 13.1.16.1 Business overview
      • 13.1.16.2 Products/Solutions/Services offered
    • 13.1.17 ANALYZEDIRECT, INC.
      • 13.1.17.1 Business overview
      • 13.1.17.2 Products/Solutions/Services offered
    • 13.1.18 SYNTERMED INC.
      • 13.1.18.1 Business overview
      • 13.1.18.2 Products/Solutions/Services offered
    • 13.1.19 PIE MEDICAL IMAGING B.V.
      • 13.1.19.1 Business overview
      • 13.1.19.2 Products/Solutions/Services offered
      • 13.1.19.3 Recent developments
        • 13.1.19.3.1 Product launches and upgrades
        • 13.1.19.3.2 Deals
    • 13.1.20 INFINITT HEALTHCARE CO., LTD.
      • 13.1.20.1 Business overview
      • 13.1.20.2 Products/Solutions/Services offered
      • 13.1.20.3 Recent developments
        • 13.1.20.3.1 Deals
  • 13.2 OTHER PLAYERS
    • 13.2.1 BIOTRONICS 3D
    • 13.2.2 MINNOVAA INNOVATIONS OU
    • 13.2.3 POSTDICOM
    • 13.2.4 CITIUSTECH INC.
    • 13.2.5 CEEVRA, INC.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 ADVANCED VISUALIZATION MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 EXCHANGE RATES FOR USD CONVERSION
  • TABLE 3 ADVANCED VISUALIZATION MARKET: RISK ASSESSMENT
  • TABLE 4 ADVANCED VISUALIZATION MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 5 AGE-RELATED DISEASES AND ASSOCIATED DIAGNOSTIC MODALITIES
  • TABLE 6 INDICATIVE SELLING PRICE OF ADVANCED VISUALIZATION SOLUTIONS, BY OFFERING, 2021-2023 (USD)
  • TABLE 7 INDICATIVE SELLING PRICE OF ADVANCED VISUALIZATION SOLUTIONS, BY REGION, 2021-2023 (USD)
  • TABLE 8 ADVANCED VISUALIZATION MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 9 TOP APPLICANTS FOR PATENTS RELATED TO ADVANCED VISUALIZATION, JANUARY 2011-JANUARY 2025
  • TABLE 10 ADVANCED VISUALIZATION MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021
  • TABLE 11 ADVANCED VISUALIZATION MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 REGULATIONS FOR ADVANCED VISUALIZATION MARKET IN NORTH AMERICA
  • TABLE 18 REGULATIONS FOR ADVANCED VISUALIZATION MARKET IN EUROPE
  • TABLE 19 REGULATIONS FOR ADVANCED VISUALIZATION MARKET IN ASIA PACIFIC
  • TABLE 20 REGULATIONS FOR ADVANCED VISUALIZATION MARKET IN MIDDLE EAST & AFRICA
  • TABLE 21 REGULATIONS FOR ADVANCED VISUALIZATION MARKET IN LATIN AMERICA
  • TABLE 22 ADVANCED VISUALIZATION MARKET: PORTER'S FIVE FORCES
  • TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
  • TABLE 24 KEY BUYING CRITERIA FOR END USERS
  • TABLE 25 UNMET NEEDS IN ADVANCED VISUALIZATION MARKET
  • TABLE 26 END-USER EXPECTATIONS IN ADVANCED VISUALIZATION MARKET
  • TABLE 27 ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 28 ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 29 ADVANCED VISUALIZATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 30 ADVANCED VISUALIZATION MARKET FOR IMPLEMENTATION SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 31 ADVANCED VISUALIZATION MARKET FOR CONSULTING/OPTIMIZATION SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 32 ADVANCED VISUALIZATION MARKET FOR TRAINING & EDUCATION SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 33 ADVANCED VISUALIZATION MARKET FOR POST-SALES & MAINTENANCE SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 34 ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 35 ADVANCED VISUALIZATION SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 36 ADVANCED VISUALIZATION MARKET FOR ON-PREMISE SOFTWARE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 37 ADVANCED VISUALIZATION MARKET FOR CLOUD-BASED SOFTWARE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 38 ADVANCED VISUALIZATION HARDWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 39 ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 40 ADVANCED VISUALIZATION MARKET FOR ENTERPRISE-WIDE THIN CLIENT-BASED SOLUTIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 41 ADVANCED VISUALIZATION MARKET FOR STANDALONE WORKSTATION-BASED SOLUTIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 42 ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 43 ADVANCED VISUALIZATION MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 ADVANCED VISUALIZATION MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 45 ADVANCED VISUALIZATION MARKET FOR POSITRON EMISSION TOMOGRAPHY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 46 ADVANCED VISUALIZATION MARKET FOR ULTRASOUND, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 47 ADVANCED VISUALIZATION MARKET FOR RADIOTHERAPY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 48 ADVANCED VISUALIZATION MARKET FOR NUCLEAR MEDICINE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 49 ADVANCED VISUALIZATION MARKET FOR OTHER IMAGING MODALITIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 50 ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 51 ADVANCED VISUALIZATION MARKET FOR RADIOLOGICAL/INTERVENTIONAL RADIOLOGICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 52 ADVANCED VISUALIZATION MARKET FOR CARDIOLOGICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 53 ADVANCED VISUALIZATION MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 54 ADVANCED VISUALIZATION MARKET FOR ONCOLOGICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 55 ADVANCED VISUALIZATION MARKET FOR VASCULAR APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 ADVANCED VISUALIZATION MARKET FOR NEUROLOGICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 57 ADVANCED VISUALIZATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 58 ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 59 ADVANCED VISUALIZATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 60 ADVANCED VISUALIZATION MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 61 ADVANCED VISUALIZATION MARKET FOR ACADEMIC & RESEARCH CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 62 ADVANCED VISUALIZATION MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 63 ADVANCED VISUALIZATION MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: ADVANCED VISUALIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 70 NORTH AMERICA: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 72 US: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 73 US: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 74 US: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 75 US: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 76 US: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 77 US: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 78 US: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 79 CANADA: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 80 CANADA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 81 CANADA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 82 CANADA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 83 CANADA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 84 CANADA: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 85 CANADA: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 86 EUROPE: ADVANCED VISUALIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 87 EUROPE: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 88 EUROPE: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 89 EUROPE: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 90 EUROPE: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 EUROPE: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 92 EUROPE: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 93 EUROPE: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 94 GERMANY: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 95 GERMANY: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 96 GERMANY: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 97 GERMANY: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 98 GERMANY: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 99 GERMANY: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 100 GERMANY: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 101 UK: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 102 UK: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 103 UK: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 104 UK: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 105 UK: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 106 UK: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 107 UK: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 108 FRANCE: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 109 FRANCE: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 110 FRANCE: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 111 FRANCE: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 112 FRANCE: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 113 FRANCE: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 114 FRANCE: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 115 SPAIN: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 116 SPAIN: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 SPAIN: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 118 SPAIN: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 119 SPAIN: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 120 SPAIN: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 121 SPAIN: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 122 ITALY: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 123 ITALY: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 124 ITALY: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 125 ITALY: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 ITALY: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 127 ITALY: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 128 ITALY: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 129 REST OF EUROPE: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 130 REST OF EUROPE: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 131 REST OF EUROPE: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 132 REST OF EUROPE: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 133 REST OF EUROPE: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 134 REST OF EUROPE: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 135 REST OF EUROPE: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 144 JAPAN: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 145 JAPAN: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 146 JAPAN: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 147 JAPAN: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 148 JAPAN: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 149 JAPAN: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 150 JAPAN: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 151 CHINA: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 152 CHINA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 153 CHINA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 154 CHINA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 155 CHINA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 156 CHINA: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 157 CHINA: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 158 INDIA: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 159 INDIA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 INDIA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 161 INDIA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 162 INDIA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 163 INDIA: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 164 INDIA: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 165 REST OF ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 166 REST OF ASIA PACIFIC: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 REST OF ASIA PACIFIC: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 168 REST OF ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 169 REST OF ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 170 REST OF ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 171 REST OF ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 172 LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 173 LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 174 LATIN AMERICA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 175 LATIN AMERICA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 176 LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 177 LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 178 LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 179 LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 180 BRAZIL: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 181 BRAZIL: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 182 BRAZIL: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 183 BRAZIL: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 184 BRAZIL: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 185 BRAZIL: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 186 BRAZIL: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 187 MEXICO: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 188 MEXICO: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 189 MEXICO: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 190 MEXICO: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 191 MEXICO: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 192 MEXICO: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 193 MEXICO: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 194 REST OF LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 195 REST OF LATIN AMERICA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 196 REST OF LATIN AMERICA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY DEPLOYMENT, 2022-2029 (USD MILLION)
  • TABLE 197 REST OF LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 198 REST OF LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 199 REST OF LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 200 REST OF LATIN AMERICA: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 201 MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 202 MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 203 MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 204 MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 205 MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 206 MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 207 MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 208 MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 209 GCC COUNTRIES: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 210 GCC COUNTRIES: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 211 GCC COUNTRIES: ADVANCED VISUALIZATION SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 212 GCC COUNTRIES: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 213 GCC COUNTRIES: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 214 GCC COUNTRIES: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 215 GCC COUNTRIES: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 216 REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 217 REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 218 REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 219 REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2022-2029 (USD MILLION)
  • TABLE 220 REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2022-2029 (USD MILLION)
  • TABLE 221 REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 222 REST OF MIDDLE EAST & AFRICA: ADVANCED VISUALIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 223 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ADVANCED VISUALIZATION MARKET, JANUARY 2021-DECEMBER 2024
  • TABLE 224 ADVANCED VISUALIZATION MARKET: DEGREE OF COMPETITION
  • TABLE 225 ADVANCED VISUALIZATION MARKET: APPLICATION FOOTPRINT
  • TABLE 226 ADVANCED VISUALIZATION MARKET: SOLUTION TYPE
  • TABLE 227 ADVANCED VISUALIZATION MARKET: IMAGING MODALITY FOOTPRINT
  • TABLE 228 ADVANCED VISUALIZATION MARKET: COMPONENT FOOTPRINT
  • TABLE 229 ADVANCED VISUALIZATION MARKET: END-USER FOOTPRINT
  • TABLE 230 ADVANCED VISUALIZATION MARKET: REGION FOOTPRINT
  • TABLE 231 ADVANCED VISUALIZATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 232 ADVANCED VISUALIZATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY KEY PLAYER
  • TABLE 233 ADVANCED VISUALIZATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY END USER & REGION
  • TABLE 234 ADVANCED VISUALIZATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY IMAGING MODALITY
  • TABLE 235 ADVANCED VISUALIZATION MARKET: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021-DECEMBER 2024
  • TABLE 236 ADVANCED VISUALIZATION MARKET: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 237 AGFA-GEVAERT GROUP: COMPANY OVERVIEW
  • TABLE 238 AGFA-GEVAERT GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 239 AGFA-GEVAERT GROUP: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 240 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 241 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 242 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 243 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 244 FUJIFILM HOLDINGS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 245 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021-DECEMBER 2024
  • TABLE 246 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021- SEPTEMBER 2024
  • TABLE 247 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 248 GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 249 GE HEALTHCARE: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021-DECEMBER 2024
  • TABLE 250 GE HEALTHCARE: DEALS, JANUARY 2021- JULY 2024
  • TABLE 251 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 252 SIEMENS HEALTHINEERS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 253 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 254 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 255 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021-DECEMBER 2024
  • TABLE 256 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 257 STRYKER: COMPANY OVERVIEW
  • TABLE 258 STRYKER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 259 STRYKER: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021-DECEMBER 2024
  • TABLE 260 STRYKER: DEALS, JANUARY 2021- SEPTEMBER 2024
  • TABLE 261 CHANGE HEALTHCARE (UNITEDHEALTH GROUP): COMPANY OVERVIEW
  • TABLE 262 CHANGE HEALTHCARE (UNITEDHEALTH GROUP): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 263 CHANGE HEALTHCARE (UNITEDHEALTH GROUP): DEALS, JANUARY 2021- DECEMBER 2024
  • TABLE 264 TERARECON: COMPANY OVERVIEW
  • TABLE 265 TERARECON: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 266 TERARECON: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021-DECEMBER 2024
  • TABLE 267 TERARECON: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 268 ZIOSOFT: COMPANY OVERVIEW
  • TABLE 269 ZIOSOFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 270 ZIOSOFT: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021-DECEMBER 2024
  • TABLE 271 PRO MEDICUS, LTD.: COMPANY OVERVIEW
  • TABLE 272 PRO MEDICUS, LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 273 PRO MEDICUS, LTD.: OTHER DEVELOPMENTS, JANUARY 2021-DECEMBER 2024
  • TABLE 274 CARESTREAM HEALTH: COMPANY OVERVIEW
  • TABLE 275 CARESTREAM HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 276 CARESTREAM HEALTH: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021-DECEMBER 2024
  • TABLE 277 FOVIA, INC.: COMPANY OVERVIEW
  • TABLE 278 FOVIA, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 279 FOVIA, INC.: DEALS, JANUARY 2021- DECEMBER 2024
  • TABLE 280 4DMEDICAL: COMPANY OVERVIEW
  • TABLE 281 4DMEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 282 4DMEDICAL: DEALS, JANUARY 2021- SEPTEMBER 2024
  • TABLE 283 SYNOPSYS, INC.: COMPANY OVERVIEW
  • TABLE 284 SYNOPSYS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 285 SYNOPSYS, INC.: DEALS, JANUARY 2021-DECEMBER 2024
  • TABLE 286 NOVARAD: COMPANY OVERVIEW
  • TABLE 287 NOVARAD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 288 ANALYZEDIRECT, INC.: COMPANY OVERVIEW
  • TABLE 289 ANALYZEDIRECT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 290 SYNTERMED INC.: COMPANY OVERVIEW
  • TABLE 291 SYNTERMED INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 292 PIE MEDICAL IMAGING B.V.: COMPANY OVERVIEW
  • TABLE 293 PIE MEDICAL IMAGING B.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 294 PIE MEDICAL IMAGING B.V.: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2021-DECEMBER 2024
  • TABLE 295 PIE MEDICAL IMAGING B.V.: DEALS, JANUARY 2021- SEPTEMBER 2024
  • TABLE 296 INFINITT HEALTHCARE CO., LTD.: COMPANY OVERVIEW
  • TABLE 297 INFINITT HEALTHCARE CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 298 INFINITT HEALTHCARE CO., LTD.: DEALS, JANUARY 2021- SEPTEMBER 2024
  • TABLE 299 BIOTRONICS 3D: COMPANY OVERVIEW
  • TABLE 300 MINNOVAA INNOVATIONS OU: COMPANY OVERVIEW
  • TABLE 301 POSTDICOM: COMPANY OVERVIEW
  • TABLE 302 CITIUSTECH INC.: COMPANY OVERVIEW
  • TABLE 303 CEEVRA, INC.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 ADVANCED VISUALIZATION MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 ADVANCED VISUALIZATION MARKET: RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 6 BOTTOM-UP APPROACH: END-USER SPENDING ON ADVANCED VISUALIZATION
  • FIGURE 7 ADVANCED VISUALIZATION MARKET: CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2024-2029
  • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 9 ADVANCED VISUALIZATION MARKET: TOP-DOWN APPROACH
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 ADVANCED VISUALIZATION MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 ADVANCED VISUALIZATION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 ADVANCED VISUALIZATION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 ADVANCED VISUALIZATION MARKET, BY REGION, 2024-2029
  • FIGURE 17 GROWING DEMAND FOR IMAGING TECHNOLOGIES TO DRIVE MARKET
  • FIGURE 18 SOFTWARE SEGMENT AND JAPAN TO LEAD ASIA PACIFIC MARKET IN 2024
  • FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 20 NORTH AMERICA TO DOMINATE ADVANCED VISUALIZATION MARKET DURING FORECAST PERIOD
  • FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 22 ADVANCED VISUALIZATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 24 ADVANCED VISUALIZATION MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 ADVANCED VISUALIZATION MARKET ECOSYSTEM
  • FIGURE 26 INVESTMENT AND FUNDING SCENARIO, 2021-2024
  • FIGURE 27 ADVANCED VISUALIZATION MARKET: PATENT ANALYSIS, JANUARY 2011-JANUARY 2025
  • FIGURE 28 ADVANCED VISUALIZATION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • FIGURE 30 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 31 NORTH AMERICA: ADVANCED VISUALIZATION MARKET SNAPSHOT
  • FIGURE 32 ASIA PACIFIC: ADVANCED VISUALIZATION MARKET SNAPSHOT
  • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN ADVANCED VISUALIZATION MARKET 2019-2023
  • FIGURE 34 ADVANCED VISUALIZATION MARKET: MARKET SHARE ANALYSIS, 2023
  • FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF ADVANCED VISUALIZATION VENDORS, 2024
  • FIGURE 36 EV/EBITDA OF KEY VENDORS, 2024
  • FIGURE 37 ADVANCED VISUALIZATION MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 38 ADVANCED VISUALIZATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 39 ADVANCED VISUALIZATION MARKET: COMPANY FOOTPRINT
  • FIGURE 40 ADVANCED VISUALIZATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 41 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2023)
  • FIGURE 42 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 43 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 44 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 45 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 46 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
  • FIGURE 47 STRYKER: COMPANY SNAPSHOT (2023)
  • FIGURE 48 CHANGE HEALTHCARE (UNITEDHEALTH GROUP): COMPANY SNAPSHOT (2023)
  • FIGURE 49 PRO MEDICUS, LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 50 4DMEDICAL: COMPANY SNAPSHOT (2023)
  • FIGURE 51 SYNOPSYS, INC.: COMPANY SNAPSHOT (2023)